CHONGQING LUMMY PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.69 CNY | -0.37% |
|
-0.74% | -27.69% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Chongqing Lummy Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and sale of medicines. The Companyâs medicines consist of anti-infection medicines, special medicines, infusion, Chinese patent drugs and herbal decoction pieces. The Company's main products include carbon nanoparticles suspension injection, omeprazole enteric capsules, mycobacterium phlei F.U.36 injection, levofloxacin hydrochloride and tranexamic acid and sodium chloride injection, among others. The Company distributes its products in domestic market.
Sector
Pharmaceuticals
Calendar
2024-09-01
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -27.69% | 392M | |
| +25.61% | 660B | |
| +25.87% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +7.09% | 219B | |
| -9.12% | 196B | |
| +5.01% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- 300006 Stock
- News Chongqing Lummy Pharmaceutical Co., Ltd.
- Lummy Pharma Unit Gets Regulatory Nod in China for Liver Cirrhosis Drug
